Jun. 22 at 7:24 PM
$BIAF If the company's report is real, as it is presented to be, this is a big deal. These skin cancers are very, very common, especially in the northern hemisphere (white skinned). Of course, it is a early pre-clinical report, and the market generally believes nothing without proof. Still, maybe this will develop into a pump. We will see. I am presently long, but I do trade it due to its enormous vol. I do not short.
